Re: Demand grows for early access to promising cancer drugs.
Genève
Jean
J
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D033181:Information Dissemination; D009369:Neoplasms / Q000188:drug therapy*; D010344:Patient Advocacy; D014481:United States
D000970:Antineoplastic Agents; D015507:Drugs, Investigational